Deborah Dunsire Syros Pharmaceuticals, Inc. (SYRS) insider trading activity

SYRS Quotes by TradingView

Deborah Dunsire is of Syros Pharmaceuticals, Inc.. Currently has a direct ownership of 12,000 shares of SYRS, which is worth approximately $2,400. The most recent transaction as insider was on Jun 01, 2024, when has been sold 4,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12K
0% 3M change
50.0% 12M change
Total Value Held $2,400

Deborah Dunsire Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 01 2024
BUY
Exercise of conversion of derivative security
-
4,000 Added 25.0%
12,000 Common Stock
Sep 16 2022
BUY
Grant, award, or other acquisition
-
8,000 Added 50.0%
8,000 Common Stock

Also insider at

ALXN
ALEXION PHARMACEUTICALS, INC.
Director
RARE
Ultragenyx Pharmaceutical Inc. Healthcare
MCK
MCKESSON CORP Healthcare
Director
DD

Deborah Dunsire

Cambridge, MA

Track Institutional and Insider Activities on SYRS

Follow Syros Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYRS shares.

Notify only if

Insider Trading

Get notified when an Syros Pharmaceuticals, Inc. insider buys or sells SYRS shares.

Notify only if

News

Receive news related to Syros Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SYRS